Prenatal Exposure to PBDEs and Neurodevelopment by Herbstman, Julie B. et al.
712  v o l u m e  118 | n u m b e r 5 | May 2010  •  Environmental Health Perspectives
Research | Children’s Health
Polybrominated diphenyl ethers (PBDEs) 
are widely used flame retardant compounds 
applied to a wide array of textiles, building 
materials, and electronic equipment, includ-
ing computers and televisions. Because they 
are additives rather than chemically bound 
to consumer products, they have the pro-
pensity to be released into the environment 
(Darnerud et al. 2001). PBDEs are persistent 
organic chemicals, and some congeners can 
bioaccumulate; therefore they have become 
ubiquitous contaminants detectable in the 
environment, in animals, and in humans 
(Hites 2004; Sjodin et al. 2008b).
A number of toxicologic studies have dem-
onstrated that exposure to PBDEs may have 
endocrine-disrupting effects. Most of these 
studies have focused on thyroid hormone dis-
ruption and a smaller number on disruption 
of the estrogen/androgen hormone system 
[reviewed by Darnerud (2008)]. Endocrine dis-
ruption during critical developmental periods 
may result in irreversible effects on differenti-
ating tissue, including the brain (Bigsby et al. 
1999). Causal relationships between prenatal 
exposure to PBDEs and indices of develop-
mental neurotoxicity have been observed in 
experimental animal models [reviewed by Costa 
and Giordano (2007)]. Thus, the disruption of 
endocrine pathways by prenatal exposure to 
hormonally active environmental chemicals 
may affect neurodevelopment in children.
Although the association between prenatal 
exposure to PBDEs and adverse neurodevel-
opmental effects has been observed in animal 
models, it has not been adequately explored in 
human populations. In a longitudinal cohort 
study initiated by the Columbia Center for 
Children’s Environmental Health (CCCEH), 
we examined the impact of prenatal exposures 
to selected toxicants, including PBDEs, that 
may be present in the ambient environment 
but may also have been emitted from the 
World Trade Center (WTC) buildings in New 
York City after the 11 September 2001 (9/11) 
terrorist attack. Here we report the relationship 
between prenatal PBDE and polybrominated 
biphenyl (PBB-153) measured in umbilical 
cord blood in humans and indicators of neu-
rodevelopment at 12–48 and 72 months of age.
Methods
Study population. We established a pro-
spective cohort study of women who were 
pregnant on 11 September 2001 and subse-
quently delivered at one of three downtown 
hospitals including Beth Israel, St. Vincent’s 
(and St. Vincent’s affiliated Elizabeth Seton 
Childbearing Center), which are all approxi-
mately 2 miles from the WTC site, and New 
York University Downtown Hospital, which 
is within a half-mile of the WTC site. The 
study methods have been described previously 
(Lederman et al. 2004). In brief, beginning 
12 December 2001 [when institutional review 
board (IRB) approval was obtained], women 
were approached in the hospital when they pre-
sented for labor and delivery. The women were 
briefly screened for eligibility, recruited, and 
enrolled, and they consented before delivery. 
This study was conducted in accordance with 
all applicable requirements of the United States 
(including IRB approval), and all human par-
ticipants gave written informed consent before 
participation in this study. Eligible women 
included those who were between 18 and 39 
years of age, reported smoking < 1 cigarette 
per day during pregnancy, were pregnant on 
11 September 2001 (based on their estimated 
date of conception), and reported no diabetes, 
hypertension, HIV infection or AIDS, or use 
of illegal drugs in the preceding year. Not all 
mothers agreed to have their child followed 
after birth. For example, some of the Chinese 
children were to be raised in China [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0901340) for follow-up information].
Data collection. Medical records of the 
mother and newborn were abstracted for 
information relating to pregnancy, delivery, 
and birth outcomes. Interviews were con-
ducted (generally the day after delivery) 
by bilingual interviewers in the preferred 
or native language (English, Spanish, or 
Chinese) of the participants. Demographic 
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information, reproductive history, background 
environmental exposures, occupational his-
tory, and the location of the residences and 
workplaces of the woman during each of 
the 4 weeks after 11 September 2001 were 
determined during this interview. Maternal 
intelligence was measured using the Test of 
Non-Verbal Intelligence, Second Edition 
(TONI-2), a 15-min, language-free measure 
of general intelligence that is relatively stable 
and free of cultural bias (Brown et al. 1990).
Developmental assessment. When the 
children were approximately 12, 24, and 36 
months of age, the Bayley Scales of Infant 
Development, Second Edition (BSID-II) 
were administered, providing scores from the 
Mental Development Index (MDI) and the 
Psychomotor Development Index (PDI). The 
BSID-II is a widely used developmental test 
designed for children 12–42 months of age 
that is norm-referenced and can be used to 
identify children with developmental delay. 
The assessment provides a developmental 
quotient (raw score/chronological age), gen-
erating a continuous MDI or PDI score, both 
with mean ± SD = 100 ± 15. 
When the children were 48 and 72 
months of age, the Wechsler Preschool and 
Primary Scale of Intelligence, Revised Edition 
(WPPSI-R) was administered, which measures 
cognitive development and contains verbal 
and nonverbal performance tests. We used 
the WPPSI-R because of its availability in 
Chinese, rather than the third edition. 
Not all children were available for all 
developmental assessments, resulting in dif-
ferent numbers of children tested at each age. 
Assessments were conducted in the first lan-
guage of the child (English or Chinese) by 
trained research technicians. In some cases, 
when the primary language of the child was not 
English or Chinese (e.g., Yiddish), we relied on 
maternal translation. Statistical analyses for 
this study were conducted with and without 
the children for whom the child’s primary lan-
guage was not English or Chinese (n = 30), and 
the results were similar (data not shown).
Most assessments were conducted at 
the CCCEH. However, a proportion of the 
assessments were conducted in the child’s 
home if the parents were unable or unwilling 
to come to the center to complete the fol-
low-up [see Supplemental Material, Table 1 
(doi:10.1289/ehp.0901340) for details].
Blood collection. Umbilical cord blood was 
collected at delivery, and maternal blood was 
typically collected on the day after delivery. On 
average, 30.7 mL blood was collected from the 
umbilical cord, and 30–35 mL blood was col-
lected from the mothers. Samples were trans-
ported to the laboratory and processed within 
several hours of collection. The buffy coat, 
packed red blood cells, and plasma were sepa-
rated and stored at –70°C. Frozen plasma from 
210 cord samples was transferred on dry ice to 
the Centers for Disease Control and Prevention 
for laboratory analyses for the PBDEs and 
PBB-153. The concentrations of these chemi-
cals in the cord blood were used as an indicator 
of fetal exposure during gestation (Mazdai et al. 
2003; Qiu et al. 2009).
Laboratory methods. Details regard-
ing the analysis of the plasma samples for 
PBDEs are given elsewhere (Hovander et al. 
2000; Sjodin et al. 2004). Briefly, the sam-
ples were automatically fortified with 13C-
labeled internal standards. The samples were 
subjected to an initial liquid/liquid extrac-
tion with hexane:methyl-tert-butyl ether after 
denaturation with 1 M HCl and isopropa-
nol (Hovander et al. 2000). Thereafter, coex-
tracted lipids were removed on a silica:silica/
sulfuric acid column using the Rapid 
Trace equipment (Zymark, Hopkinton, 
MA) for automation. Final determination 
of the target analytes was performed by gas 
chromatography-isotope dilution high-res-
olution mass spectrometry employing an 
MAT95XP (ThermoFinnigan MAT, Bremen, 
Germany) instrument (Sjodin et al. 2004). 
Concentrations of target analytes were 
reported as picograms per gram whole weight 
(weight of plasma) and nanograms per gram 
lipid weight (weight of plasma lipids). The 
plasma lipid concentrations were determined 
using commercially available test kits from 
Roche Diagnostics Corp. (Indianapolis, IN) 
for the quantitative determination of total 
triglycerides (product no. 011002803-0600) 
and total cholesterol (product no. 011573303-
0600). Final determinations were made on 
a Hitachi 912 Chemistry Analyzer (Hitachi, 
Tokyo, Japan). Limits of quantification were 
determined in relation to the method blanks 
and in relation to the quantification limit of 
the instrument, which is proportional to the 
sample size. Cotinine concentrations were 
measured in cord and maternal blood by use 
of liquid chromatography in conjunction with 
atmospheric pressure ionization tandem mass 
spectrometry (Bernert et al. 1997).
The plasma samples were analyzed for the 
following PBDE congeners (by International 
Union of Pure and Applied Chemistry 
numbers): 2,2,2´,4,4´-tetraBDE (BDE-47); 
2,2´,3,4,4´-pentaBDE (BDE-85); 2,2´,4,4´,5-
pentaBDE (BDE-99); 2,2´,4,4´,6-pentaBDE 
(BDE-100);  2,2´,4,4´,5,5´-hexaBDE 
(BDE-153);  2,2´,4,4´,5,6´-hexaBDE 
(BDE-154); 2,2´,3,4,4´,5´,6-heptaBDE 
(BDE-183); and 2,2´,4,4´,5,5´-hexaBB 
(BB-153).
Quality control/quality assurance. We 
determined background levels by measuring 
the level of target analytes in blank samples 
in the same run as the study samples (three 
blanks per 24 study samples). All concentra-
tions reported were corrected for the average 
amount present in the blank samples. The 
limit of detection (LOD) when no analytical 
background was detected in blank samples 
was defined as a signal-to-noise ratio > 3. 
When an analytical background was detected 
in the blanks, the LOD was defined as three 
times the SD of the blanks.
The plasma samples used in this cohort 
were not collected solely for the purpose of 
PBDE analysis. Therefore, we examined the 
ratio of BDE-99 over BDE-47 for any indica-
tion of contamination from indoor particu-
late matter, with the assumption that a high 
ratio would indicate sample contamination 
during sample collection. The median ratio 
of BDE-99 over BDE-47 is 1.2 in residential 
dust samples (Sjodin et al. 2008a), whereas 
in human samples this ratio is typically sig-
nificantly lower. In the 2003–2004 National 
Health and Nutrition Examination Survey 
(NHANES), the median ratio of BDE-99 to 
BDE-47 was 0.23, whereas the 95th percentile 
of this ratio was 0.43 (Sjodin et al. 2008b). 
In our study, we found that 16 of 210 sam-
ples had a BDE-99 to BDE-47 ratio > 0.43, 
corresponding to 7.6% of the samples. This 
frequency of samples having a ratio > 0.43 is 
similar to that of the NHANES survey, and we 
can thus conclude that no detectable contami-
nation occurred during the collection of the 
cord samples in this study. Statistical analyses 
for this study were conducted both including 
and excluding the aberrant samples (n = 16), 
and the results were similar (data not shown).
WTC exposure. In previous analyses in this 
cohort, we used two indices to describe expo-
sure to the WTC: geographic proximity to the 
WTC during the first month after 9/11 and 
timing of exposure relative to date of delivery. 
We found that women who lived closest to 
the WTC during the first month after 9/11 
(constituting the group we would estimate to 
have the largest exposure to the WTC) did not 
have higher concentrations of PBDEs com-
pared with those who lived farther from the 
towers in the first 4 weeks after the attack. 
However, we found that women who deliv-
ered sooner after 9/11 (constituting the group 
who were further along in their pregnancy 
on 9/11) tended to have higher cord blood 
concentrations of PBDEs (unpublished data). 
Because we quantify prenatal PBDE expo-
sure using a biological marker that integrates 
exposure from all sources, the source of the 
PBDEs is not relevant to the effect of prenatal 
exposure to PBDEs on neurodevelopment. 
To our knowledge, PBDEs are not associated 
with any other neurotoxic exposure that could 
confound the observed associations.
Statistical methods. Concentrations of 
PBDEs were lipid- and natural log-adjusted. 
PBDEs commonly detected in cord blood 
(detected in > 55% of samples) were handled 
as continuous variables in the statistical models. Herbstman et al.
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This was the case for BDEs 47, 99, 100, and 
153. We used the LOD divided by the square 
root of 2 for concentrations below the LOD. 
Based on the log-normal distribution of each 
of these BDE congeners, we also compared 
participants having cord concentrations in the 
highest 20% with those in the lowest 80% 
of the population distribution to evaluate the 
impact of having exposures at the high end of 
the exposure distribution. This categorization 
was selected because it distinguished those with 
exposures in the tail of the log-normal distribu-
tion. The majority of cord samples (> 50%) 
had levels below the limits of detection for 
BDEs 85, 154, and 183, and BB-153. We 
evaluated BDE-85 and BB-153 as dichoto-
mous measures (detected vs. nondetected); we 
did not analyze BDEs 154 and 183 because 
only 6% and 4% of the samples, respectively, 
had detectable concentrations (Table 1).
We generated descriptive statistics and 
evaluated bivariate associations using analysis of 
variance and chi-square tests to compare stra-
tum-specific means and proportions, respec-
tively. We examined the data using lowess 
curves and determined that linear models using 
natural logarithmic (ln)-transformed PBDE 
concentrations fit the data well. Therefore, 
we conducted multivariate linear regression 
analyses to evaluate the relationships between 
prenatal PBDE concentrations (using continu-
ous measures for ln-transformed BDEs 47, 
99, 100, and 153 and dichotomous measures 
for BDEs 85, 154, and 183) and continuous 
scores on developmental tests (MDI and PDI 
at 12, 24, and 36 months and Full, Verbal, 
and Performance scores at 48 and 72 months). 
We were not able to consider developmental 
test scores as dichotomous measures, using the 
test-specific recommended cutoffs for defining 
children as “delayed” or “borderline delayed” 
because of the small sample size and small 
number of children who met these criteria.
We selected covariates for inclusion in mul-
tivariate models based on their a priori asso-
ciation with neurodevelopment (Tong and Lu 
2001), including age at testing, sex of child, 
ethnicity (Asian, black, white, or other), envi-
ronmental tobacco smoke (ETS) exposure in 
the home [yes/no; based on self-report and 
validated in this data set by cotinine measured 
in cord blood, using methodology described 
by Jedrychowski et al. (2009)] and IQ of the 
mother. We also considered the inclusion of 
additional covariates if they changed the beta 
coefficient for PBDEs > 10% when they were 
added to the a priori set one at a time. This 
resulted in a final covariate set that added to our 
a priori set gestational age at birth (based on the 
best obstetric estimate), maternal age, maternal 
education, material hardship during pregnancy 
(defined as having gone without either food, 
shelter, gas/electric, clothing, or medication/
medical care because of financial constraint), 
and breast-feeding [considering both breast-
feeding duration and exclusiveness, defined by 
Lederman et al. (2008)]. The results of these 
models are presented as model 1. We also cre-
ated a model 2, which included all the previ-
ous covariates plus two study-specific variables: 
the language (including whether the mother 
aided in translation) and location (home or 
study site) of the interview and assessment. We 
explored the effects of whether the mother ate 
fish/seafood when she was pregnant (yes/no) 
and also the effects of cord blood total mercury 
and lead concentrations (continuous measures), 
but found that these covariates did not materi-
ally change the relationships between PBDE 
concentrations and developmental indicators.
To determine whether only a few cases 
could have a substantial association with the 
adjusted PBDE regression coefficients, we 
used AV plots to examine the residuals from 
the regression lines for the adjusted PBDE 
regression coefficients to find possible influen-
tial cases. These are cases that are outliers both 
for the outcomes (PDI, MDI, WPPSI) and 
the independent variables of interest (PBDE 
compounds). When the possible influential 
Table 1. Concentrations (ng/g lipid) of PBDEs and BB-153 in cord blood.
Cord blood measurements (n = 210)
Cord measurements with > 1  
neurodevelopmental test (n = 152)
n % > LOD Median Maximum n % > LOD Median Maximum
BDE-47 210 81.4 11.2 613.1 152 83.6 11.2 613.1
BDE-85 189 18.5 0.7 16.6 141 17.7 0.7 16.6
BDE-99 210 59.5 3.2 202.8 152 57.9 3.2 202.8
BDE-100 209 63.6 1.4 71.9 152 69.1 1.4 71.9
BDE-153 201 49.8 0.7 28.9 143 55.9 0.7 28.9
BDE-154 200 6.0 0.6 11.1 146 6.2 0.6 11.1
BDE-183 204 3.9 0.6 2.8 147 4.1 0.6 2.8
BB-153 197 11.2 0.6 8.0 145 13.1 0.9 8.0
Table 2. Characteristics of all cohort members (n = 329), participants with cord blood measurement of 
PBDEs (n = 210), and those included in our study sample (n = 152).
All participants 
(n = 329)
Cord PBDEs  
(n = 210)
Cord measurements > 1 
neurodevelopmental test 
(n = 152)
Maternal characteristics
Maternal age (years)  30.2 ± 5.2 30.4 ± 5.1 31.2 ± 4.9**
Maternal education 
< High school 61 (18.5) 45 (21.4) 21 (13.8)
High school 56 (17.0) 36 (17.1) 25 (16.4)
Some college 73 (22.2) 46 (21.9) 34 (22.4)
Four year college degree 72 (21.9) 41 (19.5) 34 (22.4)
Post college education 67 (20.4) 42 (20.0) 38 (25.0)
Race/ethnicity 
Chinese 92 (28.0) 72 (34.3)* 41 (27.0)
Asian (non-Chinese) 21 (6.4) 13 (6.2) 9 (5.9)
Black 50 (15.2) 27 (12.8) 23 (15.1)
White 133 (40.4) 77 (36.7) 62 (40.8)
Other 33 (10.0) 21 (10.0) 17 (11.2)
Married/ living with partner  265 (80.6) 172 (81.9) 126 (82.9)
TONI-2 score 95.8 ± 11.4 95.8 ± 11.3 95.8 ± 13.0
Missing TONI  118 (35.9) 82 (39.0) 26 (17.1)**
Maternal exposure to ETS, reported as 
smoker in the home (%)
59 (17.9) 36 (17.1) 26 (17.1)
Ate fish during the pregnancy 233 (70.8) 150 (71.4) 110 (72.4)
Material hardship  31 (9.4) 20 (9.5) 16 (10.5)
Infant characteristics
Birth weight (g)  3419.5 ± 469.1 3399.2 ± 472.5 3412.0 ± 487.4
Birth length (cm)  50.8 ± 2.8 50.5 ± 2.7* 50.6 ± 2.7
Birth head circumference (cm)  34.2 ± 1.5 34.2 ± 1.4 34.3 ± 1.5
Gestational age (days)  276.8 ± 9.9 276.4 ± 10.4 276.6 ± 9.5
Male 161 (48.9) 105 (50.0) 77 (50.7)
Proportion of first year breast-fed  
(% of 1 year) 
0.24 ± 0.28 0.22 ± 0.27 0.26 ± 0.28
Residential characteristics
Worked and/or lived within 1 mile of the 
WTC during any of the 4 weeks after 9/11
62 (18.8) 43 (20.5) 32 (21.0)
Worked and/or lived within 2 mile of the 
WTC during any of the 4 weeks after 9/11
141 (42.8) 94 (44.8) 73 (48.0)
Values are mean ± SD or n (%).
*Statistical comparison between those in the full cohort and those with cord blood measurements, p < 0.05. **Statistical 
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cases were removed, the largest changes in the 
regression coefficients were < 1 point, with no 
changes in significance levels, using p < 0.05 
as a cut point. 
Results
Median cord concentrations of PBDE conge-
ners 47, 99, and 100 in the full cohort were 
11.2, 3.2, and 1.4 ng/g lipid; 81.4%, 59.5%, 
and 63.6%, respectively, were above the LOD 
(Table 1). Overall concentrations and the 
proportion of participants with PBDE con-
centrations above the LOD were not signifi-
cantly different in the study subsample. The 
proportion of participants with detectable 
concentrations of BDEs 85, 153, 154, and 
183 ranged from approximately 4% to 50%. 
PBDE congeners 47, 99, and 100 were highly 
intercorrelated (r = 0.74–0.88).
Characteristics of the full cohort (n = 
329), the subset of 210 participants with cord 
PBDE (and PBB) measurements, and the 
subset of 152 with both cord measurement 
and a neurodevelopmental test are shown 
in Table 2. Those with cord blood measure-
ments were similar to the full cohort except 
that there were proportionally more Chinese 
participants with cord blood measurements 
(34.3% compared with 28.0% in the full 
cohort) and those with measurements were 
slightly smaller in birth length. The study 
sample and the full cohort were similar except 
that mothers included in the study sample 
were slightly older at the time of delivery 
(31.2 vs. 30.2 years, p < 0.01) and were more 
educated (not statistically significant). Those 
in the study sample were more likely to have 
completed maternal IQ measurements, which 
is expected, considering that this measure-
ment was collected at follow-up visits, not at 
the delivery hospital. There were no differ-
ences in the proportions working and/or liv-
ing closest to the WTC (within 1 or 2 miles) 
at the time of the attack.
There were 118, 117, 114, 104, and 96 
children with available cord PBDE measure-
ments who also had a developmental assess-
ment at 12, 24, 36, 48, and 72 months of age, 
respectively. For those assessed at all of these 
time points, the median cord plasma concen-
trations of BDE-47 and 99 were 12.1 ng/g 
lipid and 3.5 ng/g lipid. For BDE-100, median 
concentrations were approximately 1.5 ng/g 
lipid for children assessed at 12–48 months; 
for those assessed at 72 months, the median 
cord blood concentration was 1.4 ng/lipid.
In cross-sectional analyses using multivariate 
linear regression, prenatal exposure to BDE-47 
was negatively associated with neurodevelop-
mental indices (Table 3). These relationships 
were statistically significant for 12-month PDI 
(borderline), 24-month MDI, and 48-month 
Full and Verbal IQ scores. For every ln-unit 
change in BDE-47, scores were, on average, 2.1–
3.1 points lower on developmental indices. For 
BDE-99 (Table 4), statistically significant nega-
tive associations were detected for 24-month 
MDI [β = –2.82; 95% confidence interval (CI), 
–4.86 to –0.78]. Prenatal exposure to BDE-100 
was negatively associated with neurodevelop-
mental indices (Table 5), with statistically sig-
nificant relationships observed for 24-month 
MDI, 48-month Full, Verbal, and Performance 
IQ scores, and 72-month Performance IQ 
scores. For every ln-unit change in BDE-100, 
scores were, on average, 3.4–4.0 points lower on 
developmental indices. For BDE-153 (Table 6), 
statistically significant negative associations were 
detected for 48-month and 72-month Full 
and Performance IQ scores. For every ln-unit 
change in BDE-153, scores were, on average, 
3.1–4.2 points lower. The strength of associa-
tion between BDE-153 and IQ scores was much 
larger in the adjusted models compared with the 
Table 3. Association (95% CIs) between prenatal exposure to BDE-47 and indices of neurodevelopment at 12, 24, 36, 48, and 72 months of age. 
Model 2b
Age 
(months) n
Univariate 
Change in score per ln-unit
Model 1a  
Change in score per ln-unit Change in score per ln-unit
Change in score per increase from 
the 25th to 75th percentile (IQRc)
MDI 12 118 –0.88 (–2.20 to 0.44) –0.60 (–2.04 to 0.83) –0.64 (–2.11 to 0.82) –1.06 (–3.49 to 1.36)
24 117 –2.88 (–5.20 to –0.55)* –2.65 (–4.82 to –0.48)* –3.12 (–5.25 to –0.99)* –5.16 (–8.68 to –1.64)*
  36 114 –0.34 (–2.60 to 1.93) –0.34 (–2.65 to 1.98) –1.05 (–3.35 to 1.26) –1.74 (–5.54 to 2.08)
PDI 12 118 –1.01 (–2.99 to 0.97) –2.10 (–4.16 to –0.04)* –2.09 (–4.20 to 0.03) –3.46 (–6.95 to 0.05) 
24 115 –0.21 (–2.13 to 1.70) –0.11 (–2.11 to 1.89) –0.29 (–2.37 to 1.79) –0.48 (–3.92 to 2.96) 
36 109 –1.52 (–4.13 to 1.08) –1.64 (–4.52 to 1.23) –1.81 (–4.69 to 1.07) –2.99 (–7.76 to 1.77)
Full 48 104 –1.98 (–4.49 to 0.53) –2.13 (–4.31 to 0.06) –2.42 (–4.71 to –0.12)* –4.00 (–7.79 to –0.20)* 
72 96 1.02 (–2.03 to 4.08) –0.12 (–2.92 to 2.69) –1.17 (–4.03 to 1.69) –1.94 (–6.67 to 2.80) 
Verbal 48 104  –1.41 (–4.00 to 1.19) –2.16 (–4.60 to 0.27) –2.75 (–5.28 to –0.22)* –4.55 (–8.73 to –0.36)* 
72 96 2.31 (–0.94 to 5.57) 1.10 (–1.78 to 3.97) 0.09 (–2.82 to 3.01) 0.15 (–4.66 to 4.98) 
Performance 48 104  –2.27 (–5.04 to 0.50) –1.76 (–4.27 to 0.74) –1.67 (–4.32 to 0.98) –2.76 (–7.15 to 1.62) 
72 96 –0.54 (–3.54 to 2.46) –1.27 (–4.22 to 1.68) –2.14 (–5.20 to 0.93) –3.54 (–8.60 to 1.54) 
aModel 1 adjusted for age at testing, race/ethnicity, IQ of mother, sex of child, gestational age at birth, maternal age, ETS (yes/no), maternal education, material hardship, and breast-
feeding. bModel 2 adjusted for all covariates in model 1 plus language and location of interview. cInterquartile range (IQR) for BDE-47 is 19.57 ng/g lipid. *CIs do not include 0.00.
Table 4. Association (95% CIs) between prenatal exposure to BDE-99 and indices of neurodevelopment at 12, 24, 36, 48, and 72 months of age.
Model 2b
Age 
(months) n
Univariate 
Change in score per ln-unit
Model 1a  
Change in score per ln-unit Change in score per ln-unit
Change in score per increase from 
the 25th to 75th percentile (IQRc)
MDI 12 118 –0.56 (–1.82 to 0.71) –0.47 (–1.85 to 0.92) –0.52 (–1.92 to 0.88) –0.83 (–3.08 to 1.41) 
24 117 –3.12 (–5.38 to –0.85)* –2.67 (–4.78 to –0.56)* –2.82 (–4.86 to –0.78)* –4.52 (–7.79 to –1.25)*
  36 114 –0.63 (–2.83 to 1.57) –0.80 (–3.03 to 1.43) –1.09 (–3.29 to 1.11) –1.75 (–5.27 to 1.78) 
PDI 12 118 0.36 (–1.53 to 2.25) –0.80 (–2.81 to 1.22) –0.74 (–2.79 to 1.31) –1.19 (–4.47 to 2.10) 
24 115 –0.33 (–2.19 to 1.54) 0.01 (–1.93 to 1.95) –0.06 (–2.03 to 1.90) –0.10 (–3.25 to 3.04) 
36 109 –0.66 (–3.18 to 1.86) –0.71 (–3.47 to 2.05) –0.89 (–3.62 to 1.84) –1.43 (–5.80 to 2.95) 
Full 48 104 –1.39 (–3.76 to 0.99) –1.41 (–3.46 to 0.64) –1.42 (–3.53 to 0.61) –2.28 (–5.66 to 0.98) 
72 96 0.30 (–2.65 to 3.25) –0.18 (–2.88 to 2.53) –0.22 (–2.97 to 2.52) –0.35 (–4.76 to 4.04) 
Verbal 48 104  –1.11 (–3.55 to 1.34) –1.72 (–3.99 to 0.55) –1.88 (–4.16 to 0.40) –3.01 (–6.67 to 0.64) 
72 96 0.99 (–2.18 to 4.16) 0.56 (–2.22 to 3.35) 0.76 (–2.02 to 3.54) 1.22 (–3.24 to 5.67) 
Performance 48 104  –1.49 (–4.11 to 1.14) –0.94 (–3.28 to 1.41) –0.86 (–3.23 to 1.52) –1.38 (–5.18 to 2.44) 
72 96 –0.54 (–3.44 to 2.35) –0.89 (–3.74 to 1.96) –1.20 (–4.16 to 1.75) –1.92 (–6.67 to 2.80) 
aModel 1 adjusted for age at testing, race/ethnicity, IQ of mother, sex of child, gestational age at birth, maternal age, ETS (yes/no), maternal education, material hardship, and breast-
feeding. bModel 2 adjusted for all covariates in model 1 plus language and location of interview. cIQR for BDE-99 is 5.60 ng/g lipid. *CIs do not include 0.00.Herbstman et al.
716  v o l u m e  118 | n u m b e r 5 | May 2010  •  Environmental Health Perspectives
univariate model. It appears that the strong posi-
tive association of maternal education between 
IQs at ages 48 and 72 months was responsible 
for much of this change.
We also evaluated the difference in mean 
developmental score comparing children who 
were in the highest 20% of the prenatal expo-
sure distribution with those in the lower 80% 
of the distribution for BDEs 47, 99, and 100 
(Figure 1). We found that, on average, chil-
dren with the higher prenatal concentrations 
of BDEs 47, 99, and 100 scored lower than 
the rest of the population on nearly all neu-
rodevelopmental indices at all time points 
(12–48 and 72 months). These differences 
ranged in magnitude; the largest differences 
were observed with all three congeners for the 
24-month MDI (statistically significant dif-
ferences of –7.7, –9.3, and –10.9 points for 
BDEs 47, 99, and 100, respectively) and for 
48-month Verbal and Full IQ scores (rang-
ing from –5.5 to –8.0 points). For BDE-153, 
adjusting for the same covariate set, those in 
the highest 20% of the exposure distribu-
tion scored, on average, 6.3 points lower at 
48 months (95% CI, –13.0 to 0.4) and 8.1 
points lower at 72 months (95% CI, –15.6 to 
–0.6) on the performance IQ scale.
We used multivariate linear regression mod-
els to evaluate whether having detectable prena-
tal concentrations of BDE-85 and BB-153 was 
significantly related to developmental indices. 
Adjusting for the exact age of the child at test 
administration, ethnicity, IQ of the mother, sex 
of the child, gestational age at birth, maternal 
age, ETS (yes/no), maternal education, mate-
rial hardship, and breast-feeding, we found that 
those with detectable cord concentrations of 
BDE-85 scored, on average, 11 points lower on 
the 24-month MDI (95% CI, –17.0 to –5.2); 
6.4 points lower on 24-month PDI (95% CI, 
–11.8 to –0.8); 7.7 points lower on 36-month 
PDI (95% CI, –15.0 to –0.4); 6.5 points lower 
on 48-month Verbal IQ (95% CI, –13.3 to 
0.2); and 6.9 points lower on 48-month Full 
IQ (95% CI, –12.8 to –0.9). There were no 
statistically significant associations between pre-
natal BB-153 levels with developmental indices 
measured at any other ages.
Discussion
We found evidence suggesting that children 
who had higher cord blood concentrations 
of BDEs 47, 99, and 100 scored lower on 
tests of mental and physical development at 
ages 12–48 and 72 months. These associations 
were significant for 12-month PDI (BDE-47); 
24-month MDI (BDEs 47, 99, and 100); 
48-month Full IQ (BDEs 47, 100, and 
153); Verbal IQ (BDEs 47 and 100) and 
Performance IQ (BDEs 100 and 153); and 
72-month full and Performance IQ (BDEs 
100 and 153). Children who were in the high-
est 20% of cord blood concentrations of BDEs 
47, 99, or 100 had significantly lower develop-
mental scores compared with children who 
were in the lower 80% of the exposure distri-
butions for these chemicals. These differences 
were particularly evident at 48 months of age.
Adverse neurodevelopmental effects asso-
ciated with prenatal PBDE exposure can be 
detected both at early ages (12–36 months) 
and as the children age (48 and 72 months). 
Neurodevelopmental deficits documented by 
the WPPSI during the preschool period are an 
important predictor of subsequent academic 
performance (Kaplan 1993). Documenting 
the first appearance of potentially longer-term 
adverse effects at early ages is also important, 
because these indicators may identify children 
who could benefit from early intervention 
programs. The identification of later deficits 
may indicate the persistence of early effects 
and/or an increase in the magnitude of effect 
Table 5. Association (95% CIs) between prenatal exposure to BDE-100 and indices of neurodevelopment at 12, 24, 36, 48, and 72 months of age.
Model 2b
Age 
(months) n
Univariate 
Change in score per ln-unit
Model 1a  
Change in score per ln-unit Change in score per ln-unit
Change in score per increase from 
the 25th to 75th percentile (IQRc)
MDI 12 118 –0.99 (–2.39 to 0.41) –0.62 (–2.16 to 0.92) –0.72 (–2.29 to 0.85) –1.00 (–3.17 to 1.18) 
24 117 –3.27 (–5.71 to –0.83)* –2.95 (–5.33 to –0.56)* –3.67 (–6.00 to –1.34)* –5.09 (–8.32 to –1.86)* 
  36 114 –0.56 (–2.97 to 1.85) –1.04 (–3.55 to 1.47) –1.89 (–4.36 to 0.58) –2.62 (–6.04 to 0.80)
PDI 12 118 –0.72 (–2.83 to 1.38) –1.98 (–4.20 to 0.24) –1.93 (–4.21 to 0.35) –2.68 (–5.84 to 0.49)
24 115 –0.10 (–2.13 to 1.93) 0.26 (–1.97 to 2.49) 0.10 (–2.22 to 2.41) 0.14 (–3.08 to 3.34)
36 109 –1.14 (–3.90 to 1.62) –0.97 (–4.10 to 2.15) –1.25 (–4.38 to 1.87) –1.73 (–6.07 to 2.59)
Full 48 104  –3.29 (–5.95 to –0.63)* –3.30 (–5.61 to –0.98)* –3.68 (–6.05 to –1.28)* –5.10 (–8.39 to –1.77)*
72 96 –1.36 (–4.79 to 2.07) –2.18 (–5.36 to 0.99) –3.10 (–6.27 to 0.06) –4.30 (–8.69 to 0.08)
Verbal 48 104  –2.29 (–5.06 to 0.48) –2.87 (–5.49 to –0.25)* –3.46 (–6.14 to –0.79)* –4.80 (–8.51 to –1.10)*
72 96 0.64 (–3.06 to 4.34) –0.70 (–4.01 to 2.60) –1.46 (–4.74 to 1.81) –2.02 (–6.57 to 2.51)
Performance 48 104 –3.90 (–6.82 to –0.98)* –3.32 (–5.98 to –0.66)* –3.37 (–6.14 to –0.60)* –4.67 (–8.51 to –0.83)*
72 96 –3.20 (–6.51 to 0.11) –3.12 (–6.45 to 0.21) –4.02 (–7.41 to –0.63)* –5.57 (–10.27 to –0.87)*
aModel 1 adjusted for age at testing, race/ethnicity, IQ of mother, sex of child, gestational age at birth, maternal age, ETS (yes/no), maternal education, material hardship, and breast-
feeding. bModel 2 adjusted for all covariates in model 1 plus language and location of interview. cIQR for BDE-100 is 2.12 ng/g lipid. *CIs do not include 0.00.
Table 6. Association (95% CIs) between prenatal exposure to BDE-153 and indices of neurodevelopment at 12, 24, 36, 48, and 72 months of age.
Model 2b
Age 
(months) n
Univariate 
Change in score per ln-unit
Model 1a  
Change in score per ln-unit Change in score per ln-unit
Change in score per increase from 
the 25th to 75th percentile (IQRc)
MDI 12 111 –0.24 (–1.74 to 1.26) 0.05 (–1.59 to 1.69) 0.02 (–1.65 to 1.68) 0.02 (–1.51 to 1.54) 
24 113 –0.42 (–2.90 to 2.06) –1.26 (–3.68 to 1.17) –1.71 (–4.07 to 0.65) –1.57 (–3.73 to 0.60) 
  36 107 1.78 (–0.54 to 4.09) 0.29 (–2.17 to 2.75) –0.05 (–2.46 to 2.37) –0.05 (–2.25 to 2.17)
PDI 12 111 –1.44 (–3.65 to 0.77) –2.02 (–4.37 to 0.33) –1.95 (–4.34 to 0.43) –1.79 (–3.98 to 0.39) 
24 111 0.90 (–1.12 to 2.92) 1.20 (–1.03 to 3.44) 1.21 (–1.06 to 3.49) 1.11 (–0.97 to 3.20) 
36 102 –0.04 (–2.62 to 2.54) 0.04 (–2.96 to 3.05) 0.03 (–3.00 to 3.05) 0.03 (–2.75 to 2.79)
Full 48 97  –0.30 (–3.14 to 2.55) –2.69 (–5.17 to –0.21)* –3.09 (–5.64 to –0.54)* –2.83 (–5.17 to –0.49)* 
72 92 0.02 (–3.28 to 3.32) –3.40 (–6.57 to –0.22)* –3.25 (–6.35 to –0.15)* –2.98 (–5.82 to –0.14)* 
Verbal 48 97  0.24 (–2.63 to 3.12) –1.93 (–4.71 to 0.85) –2.46 (–5.32 to 0.41) –2.25 (–4.87 to 0.38) 
72 92 1.74 (–1.82 to 5.29) –1.91 (–5.28 to 1.47) –1.79 (–5.05 to 1.47) –1.64 (–4.63 to 1.35) 
Performance 48 97 –1.22 (–4.37 to 1.92) –3.46 (–6.36 to –0.57)* –3.62 (–6.62 to –0.63)* –3.32 (–6.07 to –0.58)*
72 92 –2.03 (–5.23 to 1.17) –4.35 (–7.63 to –1.06)* –4.19 (–7.48 to –0.89)* –3.84 (–6.85 to –0.82)*
aModel 1 adjusted for age at testing, race/ethnicity, IQ of mother, sex of child, gestational age at birth, maternal age, ETS (yes/no), maternal education, material hardship, and breast-
feeding. bModel 2 adjusted for all covariates in model 1 plus language and location of interview. cIQR for BDE-153 is 0.85 ng/g lipid. *CIs do not include 0.00.Prenatal PBDEs and neurodevelopment
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with age, as has been shown in some animal 
studies (e.g., Viberg et al. 2003a).
Our results are consistent across conge-
ners and over time. This may be predictable 
because the PBDE congeners are highly cor-
related, and for individuals, repeated devel-
opmental scores are also correlated. Although 
the number of participants lost to follow-up 
between 12 and 72 months was relatively low 
(81% of subjects available for analyses at 12 
months were also assessed at 72 months) and 
losses are independent of exposure, our over-
all sample is relatively small. Therefore, even 
small losses to follow-up may limit our power 
to detect significant differences in multivari-
ate models. The resulting small sample size 
precluded the analysis of exposure effects on 
developmental delay, and we were unable to 
look at interactions. However, the develop-
mental deficits of the magnitude we observed 
in this study are likely to have the largest 
functional impact on those who score at the 
lower end of the population distribution.
The only other epidemiologic study 
reporting the neurodevelopmental effects of 
prenatal exposure to PBDEs was published 
recently (Roze et al. 2009). In this study of 62 
Dutch children, the authors present correla-
tions between exposure to PBDEs (measured 
during the 35th week of pregnancy) and > 20 
indices of child development and behavior at 
age 60–72 months. The authors report that 
prenatal PBDE exposure was associated with 
some adverse effects on development (reduced 
fine manipulative abilities and increased 
attentional deficits) as well as some beneficial 
effects (better coordination, better visual per-
ception, and better behavior). The authors 
evaluated, but did not find statistically sig-
nificant, correlations between prenatal PBDE 
exposures and any of the WPPSI-R domains. 
Our results are not consistent with these find-
ings. However, important differences in expo-
sure (median exposure in our population was 
4 times higher for BDEs 47 and 99; 2.3 times 
higher for BDE-100; and one-fifth their con-
centration for BDE-153), sample size, and 
statistical analyses performed may account for 
some of the observed inconsistencies.
Our results are consistent with pub-
lished toxicologic experiments [reviewed by 
Costa and Giordano (2007)]. For example, 
studies evaluating the neurodevelopmental 
effects of neonatal exposure to PBDEs in 
mice during critical developmental periods 
have reported altered habituation patterns 
(Viberg et al. 2003a, 2003b), hyperactivity 
(Gee and Moser 2008), and learning and 
memory deficits (Dufault et al. 2005; Viberg 
et al. 2003a). There is some evidence sug-
gesting that BDE-99 is more potent than 
BDE-47 (Viberg et al. 2003a) and also that 
effects worsen (or are more apparent) with age 
(Viberg et al. 2003a). In general, we observed 
the largest associations with prenatal exposure 
to BDE-100, and the associations with pre-
natal exposures were still apparent, albeit not 
consistently significant, in our smaller sample 
examined at 72 months of age.
A number of potential mechanisms have 
been proposed to explain the cognitive and 
locomotive deficits observed in animals after 
PBDE exposure during critical develop-
mental periods, including direct neurotoxic 
effects on neuronal and glial cells (Costa et al. 
2008) resulting from changes in the quantity 
of cholinergic nicotinic receptors in the hip-
pocampus (Viberg et al. 2003a) and induc-
tion of apoptotic cerebellar granule cell death 
(Reistad et al. 2006). In addition, there is 
compelling experimental and epidemiologic 
evidence suggesting that PBDEs can inter-
fere with thyroid hormone pathways (Legler 
2008). Because thyroid hormones are critical 
for normal brain development, this provides 
an attractive explanation for observed neu-
rodevelopmental effects after neonatal PBDE 
exposure (Bigsby et al. 1999; Porterfield 
2000). Toxicologic evidence corroborating 
this theory includes potentially causal associa-
tions between neonatal exposure to BDE-47, 
BDE-99, or commercial PBDE mixtures 
(DE-71 and Bromokal 70-5 DE) and reduced 
thyroxine (T4) concentrations in experimental 
murine models (Fowles et al. 1994; Hallgren 
et al. 2001; Kuriyama et al. 2007).
Although only limited human epidemi-
ologic data are available, increased levels of 
BDEs 47, 99, and 100 in dust in the homes 
of adult human males recruited through a 
U.S. infertility clinic were associated with 
altered hormone levels. PBDEs were inversely 
associated with free androgen index and with 
luteinizing and follicle-stimulating hormones 
and were positively associated with inhibin 
B, sex hormone–binding globulin, and free 
T4 (Meeker et al. 2009). In another study 
of adult males, increased serum concentra-
tions of PBDEs were positively related to T4 
and inversely related to total triiodothyronine 
(T3) and thyroid-stimulating hormone (TSH) 
(Turyk et al. 2008). The positive associations 
between PBDEs and T4 levels demonstrated 
in these human studies are not consistent 
with the results from experimental animal 
models, raising the possibility that the under-
lying mechanism of the effect of PBDEs on 
thyroid disruption may differ among species. 
However, it is difficult to extrapolate findings 
from studies evaluating exposure effects in 
adults to prenatal exposures, because PBDEs 
may exhibit differential effects on thyroid 
hormone levels at different stages of the life 
span. A recent study of PBDEs measured in 
human cord blood of infants born to a cross-
section of women delivering in Baltimore, 
Maryland, showed a consistent nonsignificant 
negative association with both total and free 
T4 in infants (Herbstman et al. 2008). More 
research is necessary to fully characterize the 
association of human prenatal exposure to 
PBDEs with thyroid hormone levels.
The exact mechanism of thyroid disruption 
by PBDEs in humans has not yet been elu-
cidated, but two potential pathways through 
which PBDE exposure could lead to thyroid 
Figure 1. Difference in mean developmental score (and 95% confidence interval around the mean) com-
paring individuals in the highest quintile (20%) of exposure with those in the lower 80% of BDEs 47, 99, 
and 100. Mean differences were adjusted for age at testing, race/ethnicity, IQ of mother, sex of child, ges-
tational age at birth, maternal age, ETS (yes/no), maternal education, material hardship, breast-feeding, 
language, and location of interview.
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disruption have been proposed [reviewed by 
Zhang et al. (2008)]. The structural similari-
ties of T4 and T3 to polyhalogenated aromatic 
hydrocarbons suggest that hydroxylated PBDE 
metabolites could displace thyroid hormones 
from thyroid transport proteins (i.e., transthy-
retin), altering free thyroid hormone levels 
(Turyk et al. 2008). Alternatively (or in addi-
tion), PBDEs might affect hormone levels by 
influencing thyroid hormone synthesis and/
or stimulating thyroid hormone metabolism 
(Szabo et al. 2009; Turyk et al. 2008). Brain 
development in the fetus is contingent on the 
precise timing of thyroid hormone levels, par-
ticularly for T4, and deviations above or below 
the normal levels can lead to developmental 
deficits (Williams 2008). The fetus originally 
derives all thyroid hormone from the mother, 
but over the course of the pregnancy, its thy-
roid gland develops, and hormones produced 
within the fetus gradually replace the mater-
nal source. The surge in maternal T4 in the 
first trimester, coupled with TSH inhibition, 
is thought to provide a supply of hormone 
during this critical developmental period, 
and alteration of T4 levels by PBDEs at this 
time could alter neurodevelopment (Williams 
2008). Although low serum T4 from maternal 
hypothyroidism during gestation (e.g., iodine 
deficiency) is known to cause mental retarda-
tion in children, elevated levels of T4 have been 
associated with increased rates of miscarriage 
(Anselmo et al. 2004) and could potentially be 
linked to neurodevelopmental problems.
Because of their similar chemical structures, 
PBDEs and polychlorinated biphenyls (PCBs) 
have been compared in terms of their potential 
health effects. Although PCBs were banned 
in most industrialized countries > 25 years 
ago, they are still measurable in human and 
environmental samples because of their long 
half-lives in the environment and in humans 
(Talsness 2008). Prenatal exposure to PCBs 
has been shown in several cohort studies to 
significantly reduce cognitive function during 
childhood [reviewed by Schantz et al. (2003)] 
and has also been associated in some studies 
with altered thyroid hormone levels (Chevrier 
et al. 2007; Herbstman et al. 2008). Because of 
the structural similarity of PCBs and PBDEs, 
it has been postulated that they exert biological 
effects through similar processes.
This study population is unique in that 
participants were initially recruited to measure 
the extent and the effects of prenatal exposure 
to contaminants (including PBDEs) that were 
potentially released by the destruction of the 
WTC towers. Studies examining environmen-
tal samples collected pre- and post-9/11 near 
the WTC site found indications of higher 
concentrations of PBDEs after the attacks 
(Litten et al. 2003) and nearer to the WTC 
disaster site (Butt et al. 2004). These trends 
may be attributable to debris containing office 
equipment known to be treated with PBDEs 
(de Wit 2002). In our study population, cord 
plasma levels of PBDEs were not significantly 
related to residential distance from the WTC 
site. There is some evidence suggesting that 
PBDE exposure may be related to the WTC 
attack based on the gestational age on 9/11, 
such that women who were in the second 
half of their pregnancy on 9/11 had children 
with higher cord concentrations of PBDEs 
(unpublished data). It is also possible that just 
after 9/11, some women had elevated levels 
of PBDEs but that these levels declined with 
the passage of time between the peak expo-
sure and delivery, resulting in lower observed 
levels. In either scenario, it is not clear how 
much this apparent association between ges-
tational age on 9/11 and exposure concentra-
tion contributes to the body burden, and it is 
certain that sources other than the WTC are 
also accountable. In this report, our interest is 
in the association between the integrated pre-
natal PBDE exposure from multiple sources 
and neurodevelopment. It is also possible that 
there are other unknown factors associated 
with PBDEs that may confound the observed 
relationships between prenatal PBDE expo-
sure and adverse neurodevelopment.
Levels of cord blood PBDEs in our popula-
tion are consistent with those reported in other 
U.S. populations (Herbstman et al. 2007; 
Mazdai et al. 2003; Wu et al. 2007). Compared 
with cord blood measurements in an inner-city 
population in Baltimore, Maryland, our study 
population had slightly lower median con-
centrations (i.e., 11.2 ng/g lipid vs. 13.6 ng/g 
lipid for BDE-47) (Herbstman et al. 2007). 
In the Baltimore cohort as well as in this 
New York City cohort, higher cord PBDE 
concentrations were associated with mothers’ 
African American or non-Asian race/ethnicity, 
although a higher proportion of the Baltimore 
population was African American (70% vs. 
15%) and a lower proportion was Asian (8% 
vs. 30%). Increasing maternal age was asso-
ciated with lower PBDE concentrations in 
the Baltimore cohort but not in New York 
City; however the median maternal age was 
also lower in Baltimore (25 years vs. 30 years) 
(Herbstman et al. 2007). The demographic 
differences between these two populations may 
explain the small differences in blood levels 
observed at the population level.
Although dietary ingestion was once 
thought to be the largest route of PBDE expo-
sure in humans, the similarity of PBDE levels 
in foods in Europe, Asia, and North America 
fails to adequately explain the high blood 
levels in the U.S. population (Frederiksen 
et al. 2009). Dust inhalation may be a more 
important exposure route to PBDEs, particu-
larly BDEs 47, 99, and 100. In a review of 
median PBDE levels in dust and air samples, 
measured BDE-47 dust levels in Europe and 
North America were 32 and 429 ng/g of dust, 
respectively. Similar disparities were observed 
for BDE-99 and BDE-100 levels (Frederiksen 
et al. 2009; Sjodin et al. 2008a). Particular 
attention should be given to this exposure 
route in young children, who are more likely 
to encounter dust because of their proximity 
to the floor. Dust is estimated to contribute 
from 80 to 93% of PBDE exposure in tod-
dlers, and their small body size compounds 
the effect of their exposures (Costa and 
Giordano 2007). In this study, we were not 
able to control for postnatal dust exposure.
In the general population, infants and tod-
dlers have the highest body burden of PBDEs, 
and along with dust exposure, exposure via 
breast milk is thought to be a major contribu-
tor to this burden (Costa et al. 2008; Toms 
et al. 2009). Breast-fed infants are estimated 
to be exposed to 306 ng/kg body weight/day 
PDBE compared with 1 ng/kg body weight/
day in adults, with the most prominent con-
geners being BDEs 47, 99, and 153 (Costa 
et al. 2008). In our study, breast-feeding rates 
were higher in children with higher cord 
PBDE levels, indicating that PBDEs meas-
ured in cord blood may underestimate the 
exposure of breast-fed children. Breast-feeding 
was, as expected, associated with higher scores 
on neurodevelopmental indices, making it an 
important potential confounder to include in 
multivariate statistical models.
Conclusions
This report is among the first epidemiologic 
studies to demonstrate inverse associations 
between elevated cord blood concentrations 
of PBDEs and adverse neurodevelopmen-
tal test scores. These findings indicate a need 
for additional work to advance our under-
standing of the effects of perinatal exposure to 
PBDEs on neurodevelopment and to evaluate 
the role of thyroid hormones in this process. 
Additional PBDE congeners not measured 
in our study should also be examined to 
determine whether other congeners, includ-
ing those that are highly brominated, play a 
role in developmental outcomes. Future work 
should also explore the possibility of interac-
tions of PBDEs with other chemicals such 
as PCBs and dichlorodiphenyldichloroeth-
ylene. Although additional studies exploring 
the associations between PBDE exposure and 
developmental effects are underway, the iden-
tification of opportunities to reduce exposure 
to these compounds should be a priority.
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